Dr. Justin Dore earned his M.S. in Kinesiology and Applied Physiology from the University of Colorado at Boulder, conducting research in the lab of David A. Roth. During his Masters’ work, Dr. Dore characterized the faulty signaling pathways leading to cardiovascular pathology in diabetics. Dr. Dore then went on to the Diabetes Unit at Harvard Medical School and then to Brandeis University where he received his Ph.D. in Molecular and Cellular Biology in 2008. During his graduate studies at Brandeis, Dr. Dore worked in the lab of Susan J. Birren studying mechanisms of stem cell differentiation and the developmental events contributing to cell fate decisions during formation of the nervous system. Prior to coming to Stonehill, Dr. Dore studied congenital cardiac defects at the National Institutes of Health and lectured in the Department of Biology at Brandeis University.
- Ph.D., 2008, Molecular & Cellular Biology, Brandeis University
- M.S., 1996, Kinesiology, University of Colorado at Boulder
- B.A., 1991, Communication, University of Massachusetts at Amherst
- National Institutes of Health (NIH) Kirschstein NRSA Pre-Doctoral Fellowship
- University Prize Instructorship
- Golden Key National Honor Society
- Understanding how injury to the nervous system results in such devastating and largely irreversible changes. The true challenge lies in identifying the critical interactions between cells and molecules that facilitate or hinder appropriate healing and therefor constitute the targets of interest from a therapeutic standpoint.
- The process of drug development and the design of small molecule inhibitors will allow for specific and efficient targeting of the critical receptors and molecules underlying many pathological processes and diseases. Such intelligent designs will minimize side effects and increase therapeutic responsiveness.